Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

Thrombosis is the largest contributor to morbidity and mortality in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Our understanding of the risk factors and pathophysiology of thrombosis in PV and ET patients is developing, including recent insights into the role of aberran...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Douglas, Kosiorek, Heidi E., Dueck, Amylou C., Hoffman, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921696/
https://www.ncbi.nlm.nih.gov/pubmed/33665170
http://dx.doi.org/10.3389/fonc.2020.636675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921696/
https://www.ncbi.nlm.nih.gov/pubmed/33665170
http://dx.doi.org/10.3389/fonc.2020.636675

Ejemplares similares